These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9562136)

  • 21. Hepatotoxicity due to pemoline (Cylert): a report of two cases.
    Pratt DS; Dubois RS
    J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):239-41. PubMed ID: 2303976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
    Pelham WE; Swanson JM; Furman MB; Schwindt H
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemoline-induced Tourette's disorder: a case report.
    Bachman DS
    Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate pemoline therapy leading to acute liver failure and liver transplantation.
    Abbiati C; Vecchi M; Rossi G; Donata MF; de Franchis R
    Dig Liver Dis; 2002 Jun; 34(6):447-51. PubMed ID: 12132793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug reaction. Pemoline and dyskinesia.
    Shuster J
    Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
    [No Abstract]   [Full Text] [Related]  

  • 26. Pemoline (Cylert)-induced hepatotoxicity.
    Elitsur Y
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):143-4. PubMed ID: 2388127
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemoline-induced autoimmune hepatitis.
    Sterling MJ; Kane M; Grace ND
    Am J Gastroenterol; 1996 Oct; 91(10):2233-4. PubMed ID: 8855756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotic side effects of psychostimulants: a 5-year review.
    Cherland E; Fitzpatrick R
    Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with FDA recommendations for pemoline.
    Sarkis EH
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623
    [No Abstract]   [Full Text] [Related]  

  • 31. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity.
    Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG
    Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pemoline and liver function.
    Jaffe SL
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):457-8. PubMed ID: 2738018
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of stimulants in adult ADHD.
    Maidment ID
    Ann Pharmacother; 2003 Dec; 37(12):1884-90. PubMed ID: 14632541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemoline hepatotoxicity and postmarketing surveillance.
    Safer DJ; Zito JM; Gardner JE
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):622-9. PubMed ID: 11392339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication for attention deficit hyperactivity disorder: commentary and response.
    Faigel HC; Heiligenstein E
    J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
    [No Abstract]   [Full Text] [Related]  

  • 39. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.